These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8013961)

  • 1. Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41.
    Turánek J; Toman M; Novák J; Krchnák V; Horavová P
    Immunol Lett; 1994 Feb; 39(2):157-61. PubMed ID: 8013961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1.
    Ding J; Lu Y; Chen Y
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):123-7. PubMed ID: 11024351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
    Becker PD; Corral RS; Guzmán CA; Grinstein S
    Vaccine; 2001 Sep; 19(32):4603-9. PubMed ID: 11535307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.
    Becker PD; Nörder M; Guzmán CA; Grinstein S
    Clin Vaccine Immunol; 2007 May; 14(5):538-43. PubMed ID: 17344349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
    Wang JJ; Steel S; Wisniewolski R; Wang CY
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
    Mohan T; Verma P; Rao DN
    Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
    Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S
    Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide.
    Masek K; Seifert J; Flegel M; Krojidlo M; Kolínsky J
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):667-9. PubMed ID: 6530904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
    Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
    J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
    Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B
    J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a self-assembling peptide derived from the envelope proteins of HIV type 1. An approach to heterovalent immunogens.
    Tripathy SP; Kumar A; Manivel V; Panda SK; Rao KV
    J Immunol; 1992 Jun; 148(12):4012-20. PubMed ID: 1534827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides corresponding to the heptad repeat motifs in the transmembrane protein (gp41) of human immunodeficiency virus type 1 elicit antibodies to receptor-activated conformations of the envelope glycoprotein.
    de Rosny E; Vassell R; Wingfield PT; Wild CT; Weiss CD
    J Virol; 2001 Sep; 75(18):8859-63. PubMed ID: 11507232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.
    Zimmerman DH; Ulrich JT; Wright C; Lloyd JP; Winship MD; Sarin PS
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):741-9. PubMed ID: 9643374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
    Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.